High affinity P2X-purinoceptor binding sites for [35S]-adenosine 5′-O-[3-thiotriphosphate] in rat vas deferens membranes

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 63-70

  Michel, Anton D ^a   Humphrey, Patrick P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

P2x; Purinoceptor; Rat vas deferens; 35S ATP S

Indexed keywords

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE 5'-O-(3-THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; CALCIUM; DRUG DERIVATIVE; MEMBRANE PROTEIN; PURINE P2 RECEPTOR; SULFUR; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATASE INHIBITOR; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM CHLORIDE; CALCIUM ION; CIBACRON BLUE F3GA; EVANS BLUE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MEMBRANE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL 5 PHOSPHATE; STAUROSPORINE; SULFONIC ACID DERIVATIVE; SULFUR 35; SURAMIN; TRITIUM;

AFFINITY LABELING; ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; COMPARATIVE STUDY; MALE; METABOLISM; RAT; VAS DEFERENS; ANIMAL TISSUE; BINDING KINETICS; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RECEPTOR AFFINITY;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CALCIUM; MALE; MEMBRANE PROTEINS; RATS; RECEPTORS, PURINERGIC P2; SULFUR RADIOISOTOPES; VAS DEFERENS;

EID: 0029671008     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15155.x     Document Type: Article

References (41)

1. 2Y purinoceptors? Pharmac. Ther., 64, 445-475.
2. ABBRACHIO, M.P., CATTABENI, F., FREEDHOLM, B.B. & WILLIAMS, M. (1993). Purinoceptor nomenclature. Drug Develop, Res., 28, 207-213.
3. BARNARD, E.A., BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci., 15,67-70.
4. BEUKERS, M.W., PIROVANO, I.M., VAN WEERT, A., KERKHOF, C.J., IJZERMAN, A.P. & SOUDIJN, W. (1993). Characterization of ecta-ATPase on human blood cells. A physiological role in platelet aggregation? Biochem. Pharmacol., 46, 1959-1966.
5. 2-purinoceptors. J. Auton. Nerv. Syst., 28, 85-88.
6. 3H]-alpha, beta-methylene ATP in rat urinary bladder membranes, Br. J. Pharmacol., 101, 291-296.
7. 2X-purinoceptors in rat urinary bladder. Br. J. Pharmacol., 112, 1151-1159.
8. 2X purinoceptor from rat vas deferens. J. Biol. Chem., 267, 17581-17587.
9. BRAKE, A.J., WAGENBACH, M.J. & JULIUS, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature, 371, 519-523.
10. 2Y subtypes. Drug Develop. Res., 31, 206-219.
11. 2-purinoceptor? Gen. Pharmacol., 16, 433-440.
12. CASCALHEIRA, J.F. & SEBASTIO, A.M. (1992). Adenine nucleotide analogues, including gamma-phosphate-substituted analogues, are metabolised extracellularly in innervated frog sartorius muscle. Eur. J. Pharmacol., 222, 49-59.
13. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
14. 2X purinoceptor ligands. Br. J. Pharmacol., 113, 1432-1438.
15. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., MCKECHNIE, K.C.W., IJERMAN, A.P., & LEFF, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
16. 2Y-purinergic receptor. J. Biol. Chem., 264, 6202-6206.
17. 2 purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. Br. J. Pharmacol., 113, 853-860.
18. 4 receptor. J. Pharmacol. Exp. Ther., 255, 46-51.
19. FINE, J., COLE, P. & DAVIDSON, J.S. (1989). Extracellular nucleotides stimulate receptor-mediated calcium mobilization and inositol phosphate production in human fibroblasts. Biochem. J., 263, 371-376.
20. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
21. 2X purinoceptors in rat vas deferens. Eur. J. Pharmacol., 263, 301-309.
22. 2 purinoceptor antagonists. Br. J. Pharmacol., 115, 2P.
23. 2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br. J. Pharmacol., 115, 177-185.
24. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 90, 5113-5117.
25. LUSTIG, K.D., SPORTIELLO, M.G., ERB, L. & WEISMAN, G.A. (1992). A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionised forms of ATP and UTP. Biochem. J., 284, 733-739.
26. 3H]α,β-methylene ATP binding sites in the rat. Naunyn Schmied. Arch. Pharmacol., 348, 608-617.
27. 3H]α,β-methylene ATP binding in rat vas deferens. Naunyn Schmied. Arch. Pharmacol., 350, 113-122.
28. 2X purinoceptors. Br. J. Pharmacol., 115, 1P.
29. 2X purinoceptors. Br. J. Pharmacol., 113, 58P.
30. MICHEL, A.D. & WHITING, R.L. (1984). Analysis of Ligand binding data using a microcomputer. Br. J. Pharmacol., 108, 144P.
31. 2u receptors on aortic endothelial cells. Br. J. Pharmacol., 109, 967-971.
32. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerised approach for the characterisation of ligand binding systems. Anal. Biochem., 107, 220-229.
33. 2 purinoceptor antagonist properties of pyridoxal-5-phosphate. Eur. J. Pharmacol., 259, 295-300.
34. TREZISK, D.J., KENNEDY, I. & HUMPHREY, P.P.A. (1993). Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br. J. Pharmacol., 110, 1055-1060.
35. 2X-purinoecptor. Naunyn-Schmied. Arch. Pharmacol.., 351, 603-609
36. 2X receptor for extracellular ATP. Nature, 371, 516-519.
37. WEBB, T.E., SIMON, J., KRISHEK, B.J., BATESON, A.N., SMART, T.G., KING, B.F., BURNSTOCK, G. & BARNARD, E.A (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett., 324, 219-225.
38. 2-purinoceptor. Eur. J. Pharmacol., 129, 217-224.
39. 2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur. J. Pharmacol., 141, 123-130.
40. YOUNT, R.G. (1975). ATP analogs. Adv. Enzymol. Relat. Areas Mol. Biol., 43, 1-56.
41. ZIGANSHIN, A.U., HOYLE, C.H.V., ZIGANSHIN, L.E. & BURNSTOCK, G. (1994). Effects of cyclopiazonic acid on contractility and ecto-ATPase activity in guinea-pig urinary bladder and vas deferens. Br. J. Pharmacol., 113, 669-674.